cephalosporin c has been researched along with sulbactam in 104 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 18 (17.31) | 18.7374 |
1990's | 34 (32.69) | 18.2507 |
2000's | 32 (30.77) | 29.6817 |
2010's | 12 (11.54) | 24.3611 |
2020's | 8 (7.69) | 2.80 |
Authors | Studies |
---|---|
Girlich, D; Leclercq, R; Naas, T; Nordmann, P | 1 |
Griggs, DJ; Piddock, LJ; Traynor, EA | 1 |
Aspinall, S; Corkill, JE; Hart, CA; McLennan, AG | 1 |
Castillo, AM; Gutierrez, J; Liebana, J; Martin, MA; Piédrola, G | 1 |
Carles, MJ; Carrière, C; Jourdan, J; Ramuz, M; Sotto, A | 1 |
Kobayashi, J; Kouda, M; Kumagai, I; Matsuzaki, H; Sugai, R | 1 |
Aldridge, KE; Sanders, CV | 1 |
Castillo, AM; Gutierrez, J; Liebana, J; Martín, MA; Mesa, P; Piedrola, G | 1 |
Akalin, HE; Baykal, M | 1 |
Acar, JF; Billot-Klein, D; Carlet, J; Goldstein, FW; Gutmann, L; Kitzis, MD; Tran Van Nhieu, G; Williamson, R | 1 |
Barry, AL; Jones, RN; Thornsberry, C; Wilson, HW | 1 |
Rice, RJ; Thompson, SE | 1 |
McDougal, LK; Thornsberry, C | 1 |
Brickley, X; Duval, J; Legrand, P; Orsoni, A; Soussy, CJ | 1 |
Ben Yaghlane, H; Boujenah, A; Labia, R; Morand, A; Pitton, JS; Sirot, D; Sirot, J; Tiwari, K | 1 |
Deguchi, K; Fukayama, S; Kato, M; Koguchi, M; Nakane, Y; Nishimura, Y; Oda, S; Sato, K; Tanaka, S; Yokota, N | 1 |
Barry, AL; Fuchs, PC; Jones, RN | 1 |
Yamabe, S | 1 |
Fu, KP; Neu, HC | 1 |
Washington, JA; Yu, PK | 1 |
Mantoku, A; Ogawara, H | 1 |
Crosby, MA; Gump, DW | 1 |
Foulds, G; Hayes, SL; Marshall, DC; McMahon, FG; O'Brien, MM; Stankewich, JP; Weidler, DJ | 1 |
Baumgärtner, M; Müller, HP; Wundt, W | 1 |
Baumgärtner, M | 1 |
Fu, KP; Kimble, EF; Konopka, EA; Zoganas, H | 1 |
Harashima, S; Okada, K; Sawae, Y; Takaki, K; Takeda, T; Tanaka, M; Umeno, M | 1 |
Chen, CH; Lee, YC; Lin, JS; Perng, RP; Yang, MH | 1 |
Harris, EB; Hastings, RC; Prabhakaran, K; Randhawa, B | 1 |
Ebina, K; Kato, S; Naganuma, H; Nakagawa, H; Ozawa, A | 1 |
Brunschwig, C; Carrière, C; Galtier, M; Geny, F; Jourdan, J; Peray, P; Ramuz, M; Sotto, A | 1 |
Bonomo, RA; Carias, LL; Rice, LB; Shlaes, DM | 1 |
Chen, X; Xu, W | 1 |
Aubert, G; Guichard, D; Vedel, G | 1 |
Zhang, J; Zhang, Y; Zhou, L | 1 |
Kato, H; Kato, N; Tanaka, Y; Tanaka-Bandoh, K; Ueno, K; Watanabe, K | 1 |
Alós, JI; Balas, D; Cogollos, R; Gomez-Graces, JL; Tajada, P | 1 |
Arakawa, Y; Ito, H; Kato, N; Kimura, K; Kurokawa, H; Ohsuka, S; Ohta, M; Suzuki, K | 1 |
Chen, DK; Chen, YF; Gu, JM; Hou, J; Hu, WZ; Jia, YX; Li, JT; Li, LJ; Liu, DM; Lu, Y; Miao, JZ; Sun, L; Wang, HL; Wang, Z; Wu, J; Zhang, XZ; Zhang, YL | 1 |
Berglöff, J; Eber, B; Gasser, R; Horwarth, R; Klein, W; Pokan, R; Reisinger, E; Sedaj, B; Seinost, G | 1 |
Hanaki, H; Nagayama, A; Nomura, S | 1 |
Cheong, YM; Chiu, C; Chow, C; Kumarasinghe, G | 1 |
Doern, GV; Jones, RN; Pfaller, MA; Salazar, JC | 1 |
Amicosante, G; Cornaglia, G; Franceschini, N; Mazzariol, A; Perilli, M; Segatore, B; Setacci, D | 1 |
Filatov, LB; Iarikova, EN; Isaev, VG; Kaletin, GI; Kaporskaia, TS; Kliasova, GA; Klimko, NN; Lapin, VA; Medvedeva, NV; Parovichnikova, EN; Porokhona, ON; Pristupa, AS; Rekhtman, GB; Rossiev, VA; Savchenko, VG; Sharov, LN; Tolkacheva, TV; Tumakov, VA | 1 |
Fukuhara, J; Furuhata, N; Ikeda, A; Kimura, F; Kouda, M; Maruyama, M; Matsuzaki, H; Nomura, H; Ohgawara, M; Ono, E; Sasaki, K; Satoh, H; Sawabe, E; Suzuki, T; Takahashi, I; Takeuchi, M; Tohi, H | 1 |
Cisterna, R; Fresnadillo, MJ; García-Rodríguez, JA; Gobernado, M; Martín, R; Perea, E; Picazo, J | 1 |
Berkeley, AS; Freedman, K; Ledger, W; Noyes, N | 1 |
Borja, J; Herreras, A | 1 |
Chifu, S; Ebihara, M; Fukunaga, H; Furuno, T; Genka, K; Harada, Y; Hiraoka, T; Hirota, N; Inuyama, M; Ishibashi, T; Iwanaga, T; Kisanuki, K; Kishikawa, R; Makie, T; Matsukizono, K; Matsuura, Y; Mitsuno, T; Namba, K; Oe, T; Shimazu, K; Sugiyama, M; Takamoto, M; Tsumori, Y; Tsurutani, H; Ueno, Y | 1 |
Azimi, PH; Barson, WJ; Janner, D; Swanson, R | 1 |
Bao, D; Fan, X; Liu, B; Zhou, L | 1 |
Dev, V; Festekjian, J; Gaw, F; Shah, D; Taylor, E | 1 |
Carmeli, Y; Castro, J; Eliopoulos, GM; Samore, MH | 1 |
Li, JT; Zhang, YL | 1 |
Chikamitsu, M; Endoh, S; Fujita, Y; Kimura, M; Sari, A; Toriumi, T | 1 |
Dehne, MG; Hempelmann, G; Mühling, J; Nopens, H; Sablotzki, A | 1 |
Aung, TH; Mo, P; Pang, KH; Po, YC; Tsang, CS; Wong, WK; Yeung, WM; Zhu, XL | 1 |
Acar, O; Eser, O; Köroğlu, A; Tiraş, B; Ustün, ME | 1 |
Carmeli, Y; Harbarth, S; Harris, AD; Samore, MH | 1 |
Li, J; Zhang, Y; Zhao, M | 1 |
Apisarnthanarak, A; Little, JR | 1 |
Calvo, A; García, R; Gómez-Lus, ML; Leturia, A; Sevillano, D; Valero, E | 1 |
Karasawa, T; Kuriyama, T; Nakagawa, K; Nakamura, S; Yamamoto, E | 2 |
Bisson, G; Edelstein, PH; Fishman, NO; Lautenbach, E; Patel, JB | 1 |
Furugo, I; Ishida, M; Takii, M; Ueda, M | 1 |
Gurses, E; Serin, S; Yalçin, AN; Zencir, M | 1 |
Balzanelli, C; Gamba, P; Redaelli de Zinis, LO | 1 |
Powell, LL; Wilson, SE | 1 |
Friedland, IR; Jones, ME; Karlowsky, JA; Sahm, DF; Thornsberry, C | 1 |
Beketov, AS; Komarov, RM; Pisarev, VV; Sidorenko, SV | 1 |
Allewelt, M; Bölcskei, PL; Lode, H; Mauch, H; Schüler, P | 1 |
Høiby, N; Walther-Rasmussen, J | 1 |
Lee, WS; Lin, ML; Liu, CY; Wang, FD | 1 |
Jones, RN; Sader, HS | 1 |
Huang, JJ; Yu, JL; Zeng, Q | 1 |
Hashikita, G; Kawakami, S; Kobayashi, S; Maesaki, S; Nagasawa, M; Okabe, T; Sasaki, K; Shibuya, S; Suzuki, N; Takayama, S; Uchida, T; Watanabe, M; Yamaguchi, T | 1 |
Chai, D; Li, Z; Pei, F; Tong, W; Wang, R | 1 |
Ferraro, SM; Giacomelli, L; Marchese-Ragona, R; Marioni, G; Ottaviano, G; Rinaldi, R; Staffieri, A; Staffieri, C | 1 |
Correia, A; Domingues, MR; Domingues, P; Fonseca, F; Henriques, I; Saavedra, MJ; Samyn, B; Sarmento, AC; van Beeumen, J | 1 |
Chin, K; Fujimura, M; Ichikawa, T; Kajimoto, S; Kamijima, S; Mikami, K; Sekita, N; Suzuki, H | 1 |
Bethel, CR; Bonomo, RA; Carey, PR; Kalp, M | 1 |
Tuğrul, HM; Yıldırım, MI | 1 |
Conklin, BC; Hutton, RA; Li, M; Skalweit, MJ; Taracila, MA | 1 |
Acicbe, O; Coban, AY; Deveci, A; Durupinar, B; Tanyel, E; Yaman, G | 1 |
Gao, ZH; Li, SM; Shen, JH; Zhang, BY | 1 |
Browning, R; Darwiche, K; Freitag, L; Kioumis, I; Li, Q; Parrish, S; Petridis, D; Porpodis, K; Ritzoulis, C; Spyratos, D; Turner, JF; Zarogoulidis, K; Zarogoulidis, P | 1 |
dos Santos, VM; Ferrer, M; Friedrichs, AK; Heinsen, FA; Knecht, C; Knecht, H; Neulinger, SC; Ott, SJ; Rosenstiel, PC; Schilhabel, A; Schmitz, RA; Schreiber, S; Zimmermann, A | 1 |
Wu, H; Xie, W; Ye, Z; Zhang, W; Zhao, C | 1 |
Gentry, CA; Williams, RJ | 1 |
Krause, KM; Nichols, WW; Pillar, CM; Shinabarger, DL; Stoneburner, A | 1 |
Gao, L; Li, Y; Lyu, Y | 1 |
Cyriac, SL; Dubashi, B; Harish, BH; Jadhav, N; Jaffa, E; Kayal, S; Matta, KK; Pattnaik, J; Pillai, US; Ponraj, M; Prakash, B; Ranjith, K; Singh, J | 1 |
Ejaz, A; Ejaz, H; Javed, H; Saleem, R; Younas, S; Zafar, A | 1 |
Kharat, AS; Khobragade, K; Palwe, S; Periasamy, H; Veeraraghavan, B | 1 |
Fujii, K; Hishiki, H; Hotta, M; Ishiwada, N; Murata, S; Ohkusu, M; Takeuchi, N | 1 |
Khalim, W; Mwesigye, J; Tungotyo, M; Twinomujuni, SS | 1 |
Anzinger, FX; Friess, H; Neumann, PA; Novotny, A; Reischl, S; Rothe, K; Stöss, C; Wilhelm, D | 1 |
Antonelli, A; Cherubini, S; D'Andrea, MM; Perilli, M; Piccirilli, A; Rossolini, GM | 1 |
Koizumi, S; Kurozumi, K | 1 |
Bahrs, C; Bartonickova, L; Burgmann, H; Hagel, S; Paulussen, E; Pletz, MW; Schneider, L; Starzengruber, P; Tobudic, S | 1 |
Cheng, Q; Guo, M; Ni, H; Shi, X; Wu, Y; Xu, Y | 1 |
5 review(s) available for cephalosporin c and sulbactam
Article | Year |
---|---|
Treatment of uncomplicated infections due to Neisseria gonorrhoeae. A review of clinical efficacy and in vitro susceptibility studies from 1982 through 1985.
Topics: Cephalosporins; Chlamydia Infections; Clavulanic Acid; Clavulanic Acids; Female; Gonorrhea; Humans; Male; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Penicillanic Acid; Penicillin Resistance; Penicillins; Pharyngeal Diseases; Quinolines; Spectinomycin; Sulbactam; Syphilis; Tetracycline | 1986 |
The role of beta-lactam antimicrobials as single agents in treatment of intra-abdominal infection.
Topics: Abdomen; Abdominal Abscess; Ampicillin; Anti-Bacterial Agents; Bacterial Infections; beta-Lactamase Inhibitors; Carbapenems; Cephalosporins; Clavulanic Acids; Drug Resistance, Bacterial; Drug Therapy, Combination; Enzyme Inhibitors; Humans; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sulbactam; Surgical Wound Infection; Ticarcillin | 2000 |
Cefotaximases (CTX-M-ases), an expanding family of extended-spectrum beta-lactamases.
Topics: beta-Lactamases; Cefotaxime; Cephalosporins; Clavulanic Acid; Drug Resistance, Bacterial; Enterobacteriaceae; Enzyme Inhibitors; Gene Transfer, Horizontal; Monobactams; Penicillanic Acid; Penicillins; Phylogeny; Sulbactam; Tazobactam | 2004 |
[Prevention of and Countermeasures for Surgical Site Infection in the Field of Skull Base Surgery].
Topics: Ampicillin; Anti-Bacterial Agents; Cephalosporins; Humans; Skull Base; Sulbactam; Surgical Wound Infection | 2022 |
Efficacy and Safety of Different Antibiotic Therapies for Bone and Joint Infections: A Network Meta-analysis of Randomized Controlled Trials.
Topics: Ampicillin; Anti-Bacterial Agents; Cephalosporins; Humans; Linezolid; Network Meta-Analysis; Randomized Controlled Trials as Topic; Sulbactam | 2023 |
13 trial(s) available for cephalosporin c and sulbactam
Article | Year |
---|---|
[Clinical efficacy of sulbactam/cefoperazone for the treatment of geriatric patients with respiratory tract infections].
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Cefoperazone; Cephalosporins; Drug Therapy, Combination; Female; Humans; Infusions, Intravenous; Male; Respiratory Tract Infections; Sulbactam | 1995 |
Sulbactam/cefoperazone versus cefotaxime for the treatment of moderate-to-severe bacterial infections: results of a randomized, controlled clinical trial.
Topics: Adolescent; Adult; Aged; Bacteria; Bacterial Infections; beta-Lactamase Inhibitors; Cefoperazone; Cefotaxime; Cephalosporins; Drug Therapy, Combination; Enzyme Inhibitors; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Respiratory Tract Infections; Skin Diseases, Bacterial; Sulbactam; Urinary Tract Infections | 1997 |
[The empirical antibiotic therapy of patients with acute leukemias: the results of a multicenter study].
Topics: Acute Disease; Adult; Ampicillin; Anti-Bacterial Agents; Cefoperazone; Cephalosporins; Drug Therapy, Combination; Fever of Unknown Origin; Fluconazole; Gentamicins; Humans; Leukemia; Russia; Sulbactam; Time Factors; Ukraine | 1998 |
Incidence of postpartum endomyometritis following single-dose antibiotic prophylaxis with either ampicillin/sulbactam, cefazolin, or cefotetan in high-risk cesarean section patients.
Topics: Adult; Ampicillin; Antibiotic Prophylaxis; Cefazolin; Cefotetan; Cephalosporins; Cephamycins; Cesarean Section; Drug Therapy, Combination; Endometritis; Extraembryonic Membranes; Female; Hospitals, University; Humans; Labor, Obstetric; Postpartum Period; Pregnancy; Prospective Studies; Sulbactam | 1998 |
[Clinical efficacy of sulbactam/ampicillin in comparison with cefotiam in the treatment of elderly patients with pneumonia].
Topics: Aged; Aged, 80 and over; Alanine Transaminase; Ampicillin; Aspartate Aminotransferases; Cefotiam; Cephalosporins; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Infusions, Intravenous; Male; Pneumonia, Bacterial; Sulbactam; Treatment Outcome | 1998 |
Efficacy and safety of ampicillin/sulbactam and cefuroxime in the treatment of serious skin and skin structure infections in pediatric patients. UNASYN Pediatric Study Group.
Topics: Ampicillin; Cefuroxime; Cephalosporins; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Infant; Male; Prospective Studies; Skin Diseases, Bacterial; Sulbactam; Treatment Outcome | 1999 |
Complicated appendicitis: is there a minimum intravenous antibiotic requirement? A prospective randomized trial.
Topics: Administration, Oral; Adult; Ampicillin; Anti-Bacterial Agents; Antibiotic Prophylaxis; Appendicitis; Case-Control Studies; Cephalexin; Cephalosporins; Drug Therapy, Combination; Female; Follow-Up Studies; Gangrene; Humans; Infusions, Intravenous; Intestinal Perforation; Length of Stay; Male; Penicillins; Postoperative Complications; Prospective Studies; Sulbactam; Time Factors | 2000 |
Pharmacokinetics of antibiotic prophylaxis in major orthopedic surgery and blood-saving techniques.
Topics: Aged; Ampicillin; Antibiotic Prophylaxis; Blood Transfusion, Autologous; Bone and Bones; Cefamandole; Cefotiam; Cefuroxime; Cephalosporins; Drug Monitoring; Drug Therapy, Combination; Female; Fluid Therapy; Humans; Male; Metabolic Clearance Rate; Middle Aged; Orthopedic Procedures; Risk Factors; Sulbactam; Time Factors; Tissue Distribution | 2001 |
A randomized, double-blind comparison of ampicillin/sulbactam and ceftriaxone in the prevention of surgical-site infections after neurosurgery.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Ampicillin; Ceftriaxone; Cephalosporins; Double-Blind Method; Drug Therapy, Combination; Female; Hong Kong; Humans; Male; Middle Aged; Sulbactam; Surgical Wound Infection | 2001 |
[Comparative clinical and epidemiological evaluation of beta-lactam antibiotics in the treatment of intraabdominal infections].
Topics: Abdomen; Anti-Bacterial Agents; Bacterial Infections; Cefepime; Cefoperazone; Cephalosporins; Clinical Trials as Topic; Costs and Cost Analysis; Drug Combinations; Humans; Imipenem; Meropenem; Models, Economic; Sulbactam; Thienamycins | 2003 |
Ampicillin + sulbactam vs clindamycin +/- cephalosporin for the treatment of aspiration pneumonia and primary lung abscess.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Ampicillin; Bacterial Infections; Cephalosporins; Clindamycin; Drug Therapy, Combination; Female; Humans; Lung Abscess; Male; Middle Aged; Pneumonia, Aspiration; Prospective Studies; Sulbactam | 2004 |
[Therapeutic effects of cefepime and sulbactam/cefoperazone on moderate and severe respiratory tract infection in children].
Topics: Anti-Bacterial Agents; Cefepime; Cefoperazone; Cephalosporins; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Infant; Male; Pneumonia, Bacterial; Sulbactam | 2005 |
Cefepime vs. cefoperazone/sulbactam in combination with amikacin as empirical antibiotic therapy in febrile neutropenia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Antibiotic Prophylaxis; Antineoplastic Agents; Cefepime; Cefoperazone; Cephalosporins; Chemotherapy-Induced Febrile Neutropenia; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Neoplasms; Sulbactam; Survival Analysis; Withholding Treatment; Young Adult | 2018 |
86 other study(ies) available for cephalosporin c and sulbactam
Article | Year |
---|---|
Molecular and biochemical characterization of the chromosome-encoded class A beta-lactamase BCL-1 from Bacillus clausii.
Topics: Amino Acid Sequence; Bacillus; Bacterial Proteins; beta-Lactamases; Chromosome Mapping; Chromosomes, Bacterial; Cloning, Molecular; Microbial Sensitivity Tests; Molecular Sequence Data; Molecular Weight; Sequence Homology, Amino Acid; Substrate Specificity | 2007 |
Activity of cefpirome combined with beta-lactamase inhibitors and affinity for the penicillin-binding proteins of methicillin-resistant Staphylococcus aureus.
Topics: Bacterial Proteins; beta-Lactamase Inhibitors; Carrier Proteins; Cefpirome; Ceftazidime; Cephalosporins; Clavulanic Acid; Clavulanic Acids; Drug Combinations; Drug Synergism; Hexosyltransferases; Methicillin; Methicillin Resistance; Microbial Sensitivity Tests; Muramoylpentapeptide Carboxypeptidase; Mutation; Penicillin-Binding Proteins; Peptidyl Transferases; Staphylococcus aureus; Sulbactam | 1992 |
Characterization of a beta-lactamase produced by Pseudomonas paucimobilis.
Topics: beta-Lactamase Inhibitors; beta-Lactamases; Cephalosporins; Chromosomes, Bacterial; Clavulanic Acid; Clavulanic Acids; Drug Resistance, Microbial; Molecular Weight; Penicillanic Acid; Penicillin Resistance; Penicillins; Pseudomonas; Sulbactam; Tazobactam | 1991 |
A comparative study of the activity of first and second generation cephalosporins and their combinations with beta-lactamase inhibitors against Bacteroides fragilis.
Topics: Bacteroides fragilis; beta-Lactamase Inhibitors; beta-Lactamases; Cephalosporins; Clavulanic Acid; Clavulanic Acids; Drug Interactions; Humans; Microbial Sensitivity Tests; Sulbactam | 1991 |
[Kinetics of serum activity of beta-lactamases inhibitors. Development of a biologic assay].
Topics: beta-Lactamases; Cephalosporins; Clavulanic Acids; Humans; Indicators and Reagents; Sulbactam | 1991 |
[Combined effect of sulbactam/cefoperazone and other antibiotics against clinical isolates of multi-resistant strains. II. In vitro combined effects of sulbactam/cefoperazone with imipenem/cilastatin, cefuzonam, flomoxef, amikacin or tobramycin].
Topics: Amikacin; Anti-Bacterial Agents; Bacteria; Cefoperazone; Ceftizoxime; Cephalosporins; Cilastatin; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Humans; Imipenem; Sulbactam; Tobramycin | 1991 |
Antimicrobial treatment of pelvic inflammatory disease.
Topics: Ampicillin; Cephalosporins; Cost-Benefit Analysis; Drug Therapy, Combination; Female; Humans; Pelvic Inflammatory Disease; Sulbactam | 1990 |
In vitro anaerobic data on ticarcillin/clavulanate. A review of an ongoing survey.
Topics: Ampicillin; Bacteria; Bacteroides fragilis; beta-Lactamase Inhibitors; Cephalosporins; Clavulanic Acid; Clavulanic Acids; Clindamycin; Drug Evaluation, Preclinical; Drug Therapy, Combination; Microbial Sensitivity Tests; Penicillins; Sulbactam; Ticarcillin | 1990 |
Increase in the activity of third-generation cephalosporins in combination with clavulanic acid and Sulbactam against Bacteroides fragilis.
Topics: Bacteroides fragilis; Cephalosporins; Clavulanic Acids; Drug Therapy, Combination; Microbial Sensitivity Tests; Sulbactam | 1990 |
[In vitro antibiotic susceptibility of staphylococci].
Topics: Aminoglycosides; Ampicillin; Anti-Bacterial Agents; Cephalosporins; Humans; Microbial Sensitivity Tests; Ofloxacin; Staphylococcus; Sulbactam; Vancomycin | 1989 |
Dissemination of the novel plasmid-mediated beta-lactamase CTX-1, which confers resistance to broad-spectrum cephalosporins, and its inhibition by beta-lactamase inhibitors.
Topics: beta-Lactamase Inhibitors; beta-Lactamases; Cephalosporins; Clavulanic Acids; DNA, Bacterial; Drug Resistance, Microbial; Drug Synergism; Enterobacteriaceae; Genes, Bacterial; Humans; Nucleic Acid Hybridization; Penicillanic Acid; Penicillin Resistance; Penicillins; R Factors; Sulbactam; Tazobactam | 1988 |
In vitro antimicrobial activity of cefoperazone-sulbactam combinations against 554 clinical isolates including a review and beta-lactamase studies.
Topics: Bacteria; Bacterial Infections; beta-Lactamase Inhibitors; beta-Lactamases; Cefoperazone; Cephalosporins; Drug Combinations; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Sulbactam | 1985 |
The role of beta-lactamase in staphylococcal resistance to penicillinase-resistant penicillins and cephalosporins.
Topics: beta-Lactamase Inhibitors; beta-Lactamases; Cephalosporins; Cephalothin; Clavulanic Acid; Clavulanic Acids; Methicillin; Microbial Sensitivity Tests; Oxacillin; Penicillanic Acid; Penicillin Resistance; Penicillinase; Penicillins; Staphylococcus aureus; Sulbactam | 1986 |
[Activity of 9 beta-lactam antibiotics combined with clavulanic acid or sulbactam against the strains of broad-spectrum beta-lactamase (CTX-1) producing Enterobacteriaceae isolated at the Henri Mondor Hospital].
Topics: Anti-Bacterial Agents; Aztreonam; beta-Lactamases; Cephalosporins; Citrobacter; Clavulanic Acid; Clavulanic Acids; Drug Resistance, Microbial; Drug Synergism; Enterobacter; Enterobacteriaceae; Escherichia coli; Humans; Imipenem; Klebsiella; Klebsiella pneumoniae; Microbial Sensitivity Tests; Sulbactam; Thienamycins | 1988 |
The kinetics of SHV-2 plasmid-mediated beta-lactamase compared to those of the parent enzyme from which it is derived.
Topics: Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Clavulanic Acids; Escherichia coli; Kinetics; Plasmids; Sulbactam | 1988 |
[Antimicrobial activity of sulbactam/cefoperazone. Comparison with other new cephems].
Topics: Bacteria; Cefoperazone; Cephalosporins; Drug Combinations; Drug Resistance, Microbial; Sulbactam | 1987 |
Effect of beta-lactamase inhibitors on the antimicrobial activity of cefoperazone, cefotaxime, and ceftizoxime against aerobic and anaerobic beta-lactamase producing bacteria.
Topics: Bacteria, Aerobic; Bacteroides fragilis; beta-Lactamase Inhibitors; Cefoperazone; Cefotaxime; Ceftizoxime; Cephalosporins; Clavulanic Acid; Clavulanic Acids; Drug Interactions; Microbial Sensitivity Tests; Sulbactam | 1987 |
Spectrophotometric determination of inhibitory effects of CP-45899 on beta-lactamase with benzylpenicillin and nitrocefin.
Topics: Bacillus cereus; beta-Lactamase Inhibitors; beta-Lactamases; Cephalosporins; Cytochrome c Group; Hydrolysis; Oxidation-Reduction; Penicillanic Acid; Penicillin G; Spectrophotometry; Sulbactam | 1980 |
Synergistic activity of cefoperazone in combination with beta-lactamase inhibitors.
Topics: Anti-Bacterial Agents; Bacteria; beta-Lactamase Inhibitors; beta-Lactams; Cefoperazone; Cefotaxime; Cephalosporins; Clavulanic Acid; Drug Synergism; Penicillanic Acid; Sulbactam | 1981 |
Bactericidal activity of cefoperazone with CP-45,899 against large inocula of beta-lactamase-producing Haemophilus influenzae.
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; Cefoperazone; Cephalosporins; Drug Synergism; Haemophilus influenzae; Penicillanic Acid; Sulbactam | 1981 |
Interaction of beta-lactamase of Streptomyces cacaoi. II. CP-45,899, izumenolide and cephamycins.
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; Cephalosporins; Cephamycins; Lactones; Penicillanic Acid; Streptomyces; Sulbactam | 1981 |
Activity of cefoperazone and two beta-lactamase inhibitors, sulbactam and clavulanic acid, against Bacteroides spp. correlated with beta-lactamase production.
Topics: Anti-Bacterial Agents; Bacteroides; beta-Lactamase Inhibitors; beta-Lactamases; Cefoperazone; Cell Membrane Permeability; Cephalosporins; Clavulanic Acids; Drug Synergism; Edetic Acid; Microbial Sensitivity Tests; Penicillanic Acid; Sulbactam | 1982 |
Pharmacokinetics of sulbactam in humans.
Topics: Adult; Ampicillin; Cefoperazone; Cephalosporins; Drug Combinations; Drug Interactions; Gas Chromatography-Mass Spectrometry; Humans; Kinetics; Male; Penicillanic Acid; Penicillin G; Sulbactam | 1983 |
[Antibiotic activity and synergism of ceftazidime and netilmicin against gram-negative pathogenic bacteria].
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; Cefsulodin; Ceftazidime; Cephalosporins; Clavulanic Acid; Clavulanic Acids; Drug Resistance, Microbial; Drug Synergism; Enterobacteriaceae; Gentamicins; Gram-Negative Bacteria; Netilmicin; Penicillanic Acid; Sulbactam | 1983 |
[Cefoperazone, cefsulodin and ceftazidime--3 cephalosporins active against Pseudomonas in comparison with their monobactam analogs].
Topics: beta-Lactamase Inhibitors; Cefoperazone; Cefsulodin; Ceftazidime; Cephalosporins; Chemical Phenomena; Chemistry; Clavulanic Acid; Clavulanic Acids; Drug Resistance, Microbial; Humans; Monobactams; Penicillanic Acid; Pseudomonas aeruginosa; Pseudomonas Infections; Sulbactam | 1983 |
Synergistic activity of cefsulodin combined with cefoxitin and sulbactam against Bacteroides species.
Topics: Bacteroides; beta-Lactamase Inhibitors; Cefoxitin; Cefsulodin; Cephalosporins; Drug Resistance, Microbial; Drug Synergism; Penicillanic Acid; Species Specificity; Sulbactam | 1984 |
The in vitro activity of beta-lactamase inhibitors in combination with cephalosporins against M. tuberculosis.
Topics: beta-Lactamase Inhibitors; Cefamandole; Cefotaxime; Ceftriaxone; Cephalosporins; Cephapirin; Drug Synergism; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Sulbactam | 1995 |
beta-Lactamase activity in mycobacteria including Mycobacterium avium and suppression of their growth by a beta-lactamase-stable antibiotic.
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; Cefepime; Cell Division; Cephalosporins; Clavulanic Acid; Clavulanic Acids; Drug Resistance, Microbial; Isoniazid; Microbial Sensitivity Tests; Mycobacterium; Mycobacterium avium; Penicillanic Acid; Streptomycin; Sulbactam; Tazobactam | 1995 |
Antibiotic-associated hemorrhagic colitis without Clostridium difficile toxin in children.
Topics: Adolescent; Amoxicillin; Ampicillin; Anti-Bacterial Agents; Cefdinir; Cephalosporins; Child; Child, Preschool; Colitis; Enterocolitis, Pseudomembranous; Female; Gastrointestinal Hemorrhage; Humans; Male; Retrospective Studies; Sulbactam | 1995 |
An enzymatic method for assaying sulbactam in human serum: comparison with high performance liquid chromatography.
Topics: Adult; beta-Lactamase Inhibitors; beta-Lactamases; Cephalosporins; Chromatography, High Pressure Liquid; Female; Humans; Male; Middle Aged; Spectrophotometry; Sulbactam | 1995 |
Molecular genetics of resistance to both ceftazidime and beta-lactam-beta-lactamase inhibitor combinations in Klebsiella pneumoniae and in vivo response to beta-lactam therapy.
Topics: Abdominal Abscess; Amino Acid Sequence; Ampicillin; Animals; Base Sequence; beta-Lactamase Inhibitors; beta-Lactamases; Ceftazidime; Cephalosporin Resistance; Cephalosporins; DNA, Bacterial; Drug Therapy, Combination; Escherichia coli; Klebsiella Infections; Klebsiella pneumoniae; Molecular Biology; Molecular Sequence Data; Penicillanic Acid; Penicillin Resistance; Piperacillin; Piperacillin, Tazobactam Drug Combination; R Factors; Rats; Sulbactam | 1996 |
[In vitro antibacterial activity of sulperazone on multi-resistant strains of bacteria from burn wounds].
Topics: Anti-Bacterial Agents; Burns; Cefoperazone; Cephalosporins; Drug Combinations; Drug Resistance, Multiple; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Staphylococcus aureus; Staphylococcus epidermidis; Sulbactam | 1995 |
In-vitro activity of cephalosporins alone and combined with sulbactam against various strains of Acinetobacter baumannii with different antibiotic resistance profiles.
Topics: Acinetobacter; Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Drug Resistance, Microbial; Microbial Sensitivity Tests; Sulbactam | 1996 |
[In vitro antibacterial activity of cefoperazone-sulbactam].
Topics: Acinetobacter; Anti-Bacterial Agents; Bacteroides fragilis; Cefoperazone; Cephalosporins; Drug Combinations; Enterobacteriaceae; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Sulbactam | 1995 |
[In vitro activities of sulopenem, a new parenteral penem, against anaerobes].
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Bacteria, Anaerobic; beta-Lactamases; beta-Lactams; Cecum; Cefoperazone; Ceftizoxime; Cephalosporins; Clostridioides difficile; Drug Stability; Drug Therapy, Combination; Imipenem; Lactams; Male; Mice; Mice, Inbred ICR; Sulbactam; Thienamycins | 1996 |
Antimicrobial susceptibilities of Campylobacter jejuni and Campylobacter coli to 12 beta-lactam agents and combinations with beta-lactamase inhibitors.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactamases; Campylobacter coli; Campylobacter jejuni; Cephalosporins; Clavulanic Acid; Clavulanic Acids; Enzyme Inhibitors; Microbial Sensitivity Tests; Penicillanic Acid; Penicillins; Sulbactam; Tazobactam | 1996 |
Molecular aspects of high-level resistance to sulbactam-cefoperazone in Klebsiella oxytoca clinical isolates.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Bacteriophages; Base Sequence; beta-Lactamases; Blotting, Southern; Cefoperazone; Cephalosporins; Cloning, Molecular; Culture Media; Databases, Factual; Drug Therapy, Combination; Indicators and Reagents; Klebsiella; Klebsiella Infections; Molecular Sequence Data; Molecular Weight; Nucleic Acid Hybridization; Plasmids; Sulbactam | 1996 |
Cases of Lyme borreliosis resistant to conventional treatment: improved symptoms with cephalosporin plus specific beta-lactamase inhibition.
Topics: beta-Lactamase Inhibitors; Cefoperazone; Cephalosporins; Drug Resistance, Microbial; Drug Therapy, Combination; Enzyme Inhibitors; Female; Humans; Infusions, Intravenous; Lyme Disease; Male; Middle Aged; Sulbactam | 1995 |
Tazobactam-piperacillin compared with sulbactam-ampicillin, clavulanic acid-ticarcillin, sulbactam-cefoperazone, and piperacillin for activity against beta-lactamase-producing bacteria isolated from patients with complicated urinary tract infections.
Topics: Ampicillin; beta-Lactamase Inhibitors; Cefoperazone; Cephalosporins; Clavulanic Acid; Clavulanic Acids; Colony Count, Microbial; Dose-Response Relationship, Drug; Drug Therapy, Combination; Enzyme Inhibitors; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Penicillins; Piperacillin; Retrospective Studies; Sulbactam; Tazobactam; Ticarcillin; Urinary Tract; Urinary Tract Infections | 1997 |
In vitro activity of cefoperazone-sulbactam: Singapore experience.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Cefoperazone; Cephalosporin Resistance; Cephalosporins; Drug Therapy, Combination; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Singapore; Sulbactam | 1996 |
Multicenter evaluation of antimicrobial resistance to six broad-spectrum beta-lactams in Colombia using the Etest method. The Colombian Antimicrobial Resistance Study Group.
Topics: Anti-Bacterial Agents; Aztreonam; beta-Lactam Resistance; Cefepime; Cefoperazone; Cefotaxime; Ceftazidime; Cephalosporinase; Cephalosporins; Cohort Studies; Colombia; Enterobacteriaceae; Gram-Negative Bacteria; Humans; Imipenem; Microbial Sensitivity Tests; Reproducibility of Results; Staphylococcus; Sulbactam | 1997 |
Ceftazidime and aztreonam resistance in Providencia stuartii: characterization of a natural TEM-derived extended-spectrum beta-lactamase, TEM-60.
Topics: Anti-Bacterial Agents; Aztreonam; beta-Lactamase Inhibitors; beta-Lactamases; Ceftazidime; Cephalosporins; Clavulanic Acid; Drug Interactions; Drug Resistance, Multiple; Enzyme Inhibitors; Isoelectric Focusing; Microbial Sensitivity Tests; Molecular Sequence Data; Monobactams; Penicillanic Acid; Providencia; Sulbactam; Tazobactam | 1998 |
[Evaluation of antibacterial activities of various antibiotics against glucose non-fermentative gram-negative rods other than Pseudomonas aeruginosa].
Topics: Anti-Bacterial Agents; Cefoperazone; Cephalosporins; Drug Resistance, Microbial; Drug Therapy, Combination; Gentamicins; Gram-Negative Aerobic Rods and Cocci; Humans; Imipenem; Minocycline; Penicillin Resistance; Penicillins; Piperacillin; Sulbactam; Thienamycins | 1998 |
[Ampicillin-sulbactam activity against respiratory isolates of Haemophilus influenzae].
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactamases; Cefuroxime; Cephalosporins; Ciprofloxacin; Drug Resistance, Microbial; Drug Therapy, Combination; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Penicillins; Respiratory Tract Infections; Sulbactam | 1998 |
Comparison of sulbactam/cefoperazone with imipenem as empirical monotherapy for febrile granulocytopenic patients.
Topics: Agranulocytosis; Anti-Bacterial Agents; Cefoperazone; Cephalosporins; Fever; Humans; Imipenem; Sulbactam; Thienamycins | 1999 |
[Study on the beta-lactamases of the Escherichia coli HX88108 resistant to ceforperazon].
Topics: Anti-Bacterial Agents; beta-Lactamases; Cefoperazone; Cephalosporin Resistance; Cephalosporins; Clavulanic Acid; Enzyme Inhibitors; Escherichia coli; Hydrolysis; Sulbactam | 1998 |
Clinical isolation and resistance patterns of and superinfection with 10 nosocomial pathogens after treatment with ceftriaxone versus ampicillin-sulbactam.
Topics: Aged; Ampicillin; Anti-Bacterial Agents; Bacteria; Ceftriaxone; Cephalosporins; Cross Infection; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Penicillins; Regression Analysis; Sulbactam; Superinfection; Survival Analysis | 2001 |
The in vitro activity of sulbactam combined with third generation cephalosporins against third generation cephalosporin-resistant bacteria.
Topics: beta-Lactamase Inhibitors; Cephalosporin Resistance; Cephalosporins; Drug Therapy, Combination; Enzyme Inhibitors; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Sulbactam | 2001 |
An anaphylactic reaction possibly associated with an intraoperative coronary artery spasm during general anesthesia.
Topics: Aged; Anaphylaxis; Anesthesia, General; Anti-Bacterial Agents; Cefoperazone; Cephalosporins; Coronary Angiography; Coronary Vasospasm; Electrocardiography; Gallstones; Humans; Intraoperative Complications; Male; Sulbactam | 2001 |
The penetration of cefoperazone and sulbactam into the lumbar intervertebral discs.
Topics: Anti-Bacterial Agents; Cefoperazone; Cephalosporins; Drug Therapy, Combination; Humans; Intervertebral Disc; Lumbar Vertebrae; Sulbactam | 2001 |
Parallel analysis of individual and aggregated data on antibiotic exposure and resistance in gram-negative bacilli.
Topics: Ampicillin; Anti-Bacterial Agents; Cephalosporins; Cohort Studies; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Fluoroquinolones; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; Male; Middle Aged; Pseudomonas; Pseudomonas Infections; Statistics as Topic; Sulbactam | 2001 |
[The inducibility of Amp C enzyme of Enterobacter cloacae and its susceptibility to enzyme inhibitor].
Topics: Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; Cephalosporins; Enterobacter cloacae; Enzyme Induction; Enzyme Inhibitors; Sulbactam | 2001 |
The role of cefoperazone-sulbactam for treatment of severe melioidosis.
Topics: Anti-Bacterial Agents; Cefoperazone; Cephalosporins; Drug Therapy, Combination; Humans; Melioidosis; Sulbactam | 2002 |
[Activity of new fluoroquinolones against clinical isolates of Acinetobacter baumannii].
Topics: Acinetobacter; Acinetobacter Infections; Ampicillin; Anti-Infective Agents; Aza Compounds; Cefepime; Cephalosporins; Ciprofloxacin; Colistin; Fluoroquinolones; Gatifloxacin; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Moxifloxacin; Nalidixic Acid; Naphthyridines; Norfloxacin; Ofloxacin; Opportunistic Infections; Quinolines; Sulbactam; Thienamycins | 2001 |
Bacteriology and antimicrobial susceptibility of gram-positive cocci isolated from pus specimens of orofacial odontogenic infections.
Topics: Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactamases; Cefazolin; Cefotaxime; Cephalosporins; Clindamycin; Corynebacterium; Drug Resistance, Bacterial; Erythromycin; Eubacterium; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Imipenem; Levofloxacin; Ofloxacin; Penicillins; Peptostreptococcus; Periodontitis; Staphylococcus; Streptococcus; Sulbactam; Thienamycins; Tooth Diseases | 2002 |
Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species: risk factors for colonization and impact of antimicrobial formulary interventions on colonization prevalence.
Topics: Academic Medical Centers; Adult; Aged; Aged, 80 and over; Ampicillin; Anti-Bacterial Agents; beta-Lactam Resistance; Carrier State; Case-Control Studies; Cefepime; Cephalosporins; Cross Infection; Drug Therapy, Combination; Drug Utilization Review; Escherichia coli Infections; Feces; Female; Formularies, Hospital as Topic; Gentamicins; Hospitals, Community; Hospitals, Urban; Humans; Infection Control; Klebsiella Infections; Length of Stay; Male; Middle Aged; Pennsylvania; Prevalence; Risk Factors; Sulbactam | 2002 |
[Microbiological and clinical studies of Haemophilus influenzae isolated at Kitakyushu Municipal Medical Center from 1996 through 1999].
Topics: Adult; Aged; Ampicillin; Anti-Infective Agents; beta-Lactamases; Cefaclor; Cephalosporins; Child, Preschool; Female; Haemophilus influenzae; Humans; Imipenem; Infant; Infant, Newborn; Levofloxacin; Male; Meningitis, Bacterial; Meropenem; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Respiratory System; Seasons; Sulbactam; Thienamycins | 2002 |
Antimicrobial susceptibility of major pathogens of orofacial odontogenic infections to 11 beta-lactam antibiotics.
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Bacteroidaceae Infections; beta-Lactams; Cefepime; Cefmetazole; Cefoperazone; Cefpirome; Ceftazidime; Ceftizoxime; Cephalosporins; Drug Resistance, Bacterial; Drug Therapy, Combination; Fusobacterium; Fusobacterium Infections; Gram-Positive Bacterial Infections; Humans; Imipenem; Lactams; Microbial Sensitivity Tests; Mouth Diseases; Penicillin G; Penicillins; Peptostreptococcus; Porphyromonas gingivalis; Prevotella; Streptococcal Infections; Streptococcus; Sulbactam | 2002 |
Surgical antibiotic prophylaxis in a Turkish university hospital.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Ampicillin; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cefazolin; Cefepime; Cephalosporins; Child; Child, Preschool; Female; Hospitals, University; Humans; Infant; Infant, Newborn; Male; Middle Aged; Penicillins; Perioperative Care; Prospective Studies; Sulbactam; Surgical Procedures, Operative; Surgical Wound Infection; Turkey | 2002 |
Acute otitis media and facial nerve paralysis in adults.
Topics: Adrenal Cortex Hormones; Adult; Aged; Ampicillin; Cephalosporins; Combined Modality Therapy; Drug Therapy, Combination; Facial Paralysis; Female; Follow-Up Studies; Humans; Male; Mastoid; Middle Aged; Middle Ear Ventilation; Otitis Media; Pneumococcal Infections; Sulbactam; Tomography, X-Ray Computed | 2003 |
Trends in antimicrobial susceptibilities among Enterobacteriaceae isolated from hospitalized patients in the United States from 1998 to 2001.
Topics: Ampicillin; Anti-Bacterial Agents; Cephalosporins; Drug Resistance, Bacterial; Enterobacteriaceae; Fluoroquinolones; Hospitalization; Humans; Intensive Care Units; Microbial Sensitivity Tests; Sulbactam; Time Factors; United States | 2003 |
In vitro activities of beta-lactam antibiotics alone and in combination with sulbactam against Gram-negative bacteria.
Topics: Acinetobacter baumannii; Ampicillin; Anti-Bacterial Agents; Aztreonam; beta-Lactams; Cefepime; Cefoperazone; Cefotaxime; Ceftazidime; Cephalosporins; Drug Combinations; Drug Resistance, Bacterial; Enterobacter cloacae; Enzyme Inhibitors; Gram-Negative Bacteria; Humans; Imipenem; Klebsiella pneumoniae; Microbial Sensitivity Tests; Serratia marcescens; Sulbactam | 2004 |
Comprehensive in vitro evaluation of cefepime combined with aztreonam or ampicillin/sulbactam against multi-drug resistant Pseudomonas aeruginosa and Acinetobacter spp.
Topics: Acinetobacter; Ampicillin; Anti-Bacterial Agents; Aztreonam; Cefepime; Cephalosporins; Drug Combinations; Drug Resistance, Multiple, Bacterial; Drug Synergism; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Sulbactam | 2005 |
[The combination effects of antibacterial agents against clinical isolated multiple-drug resistant Pseudomonas aeruginosa].
Topics: Amikacin; Anti-Bacterial Agents; Aztreonam; Cefepime; Cefoperazone; Cephalosporins; Ciprofloxacin; Drug Combinations; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Fluoroquinolones; Humans; Meropenem; Microbial Sensitivity Tests; Oxazines; Penicillanic Acid; Piperacillin; Pseudomonas aeruginosa; Sulbactam; Tazobactam; Thienamycins | 2006 |
In vitro activity of cefepime combined with sulbactam against clinical isolates of carbapenem-resistant Acinetobacter spp.
Topics: Acinetobacter; Acinetobacter baumannii; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Cefepime; Cephalosporins; Drug Resistance, Bacterial; Drug Synergism; Humans; Microbial Sensitivity Tests; Sulbactam | 2006 |
Burkholderia cepacia complex nasal isolation in immunocompetent patients with sinonasal polyposis not associated with cystic fibrosis.
Topics: Adult; Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Anti-Bacterial Agents; Burkholderia cepacia complex; Burkholderia Infections; Cefazolin; Ceftibuten; Cephalosporins; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Nasal Polyps; Ofloxacin; Prospective Studies; Sinusitis; Sulbactam | 2007 |
Biochemical Characterization of SFC-1, a class A carbapenem-hydrolyzing beta-lactamase.
Topics: Aztreonam; beta-Lactamases; Carbapenems; Catalysis; Cephalosporins; Clavulanic Acid; Electrophoresis, Polyacrylamide Gel; Escherichia coli; Hydrolysis; Kinetics; Molecular Weight; Penicillanic Acid; Penicillins; Recombinant Proteins; Serratia; Sulbactam; Tazobactam | 2007 |
[Regression of mucosa-associated lymphoid tissue lymphoma of the bladder after antibiotic therapy: a case report].
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Cefoperazone; Cephalosporins; Clarithromycin; Female; Helicobacter Infections; Humans; Lymphoma, B-Cell, Marginal Zone; Sulbactam; Urinary Bladder Neoplasms | 2008 |
Why the extended-spectrum beta-lactamases SHV-2 and SHV-5 are "hypersusceptible" to mechanism-based inhibitors.
Topics: beta-Lactamase Inhibitors; beta-Lactamases; Catalytic Domain; Cephalosporins; Crystallography, X-Ray; Kinetics; Microbial Sensitivity Tests; Mutagenesis, Site-Directed; Plasmids; Serine; Spectrum Analysis, Raman; Sulbactam | 2009 |
[Assessment of efficacies of imipenem, cefoperazone-sulbactam and cefepime in rats with experimental thigh abscess model with multidrug resistant and susceptible Acinetobacter baumannii strains].
Topics: Abscess; Acinetobacter baumannii; Acinetobacter Infections; Animals; Anti-Bacterial Agents; Cefepime; Cefoperazone; Cephalosporins; Colony Count, Microbial; Disease Models, Animal; Drug Combinations; Drug Resistance, Multiple, Bacterial; Female; Imipenem; Random Allocation; Rats; Rats, Wistar; Serum Bactericidal Test; Soft Tissue Infections; Sulbactam; Thigh | 2011 |
Substitutions at position 105 in SHV family β-lactamases decrease catalytic efficiency and cause inhibitor resistance.
Topics: Amino Acid Substitution; Ampicillin; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Biocatalysis; Cephalosporins; Clavulanic Acid; Enzyme Inhibitors; Escherichia coli; Kinetics; Meropenem; Microbial Sensitivity Tests; Molecular Docking Simulation; Mutagenesis, Site-Directed; Structure-Activity Relationship; Substrate Specificity; Sulbactam; Thienamycins | 2012 |
In vitro effects of sulbactam combinations with different antibiotic groups against clinical Acinetobacter baumannii isolates.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Cephalosporins; Colistin; Dose-Response Relationship, Drug; Drug Antagonism; Drug Combinations; Drug Resistance, Multiple, Bacterial; Drug Synergism; Gentamicins; Meropenem; Microbial Sensitivity Tests; Minocycline; Sulbactam; Thienamycins; Tigecycline | 2012 |
[Protective effects of snake venom antimicrobial peptide OH-CATH on E. coli induced rabbit urinary tract infection models].
Topics: Amino Acid Sequence; Animals; Anti-Bacterial Agents; Cefoperazone; Cephalosporins; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Host-Pathogen Interactions; Male; Microscopy, Electron, Transmission; Molecular Sequence Data; Peptides; Rabbits; Snake Venoms; Sulbactam; Urinary Bladder; Urinary Tract Infections | 2013 |
New insights in the production of aerosol antibiotics. Evaluation of the optimal aerosol production system for ampicillin-sulbactam, meropenem, ceftazidime, cefepime and piperacillin-tazobactam.
Topics: Aerosols; Ampicillin; Anti-Bacterial Agents; Cefepime; Ceftazidime; Cephalosporins; Chemistry, Pharmaceutical; Equipment Design; Meropenem; Nebulizers and Vaporizers; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sulbactam; Thienamycins | 2013 |
Effects of β-lactam antibiotics and fluoroquinolones on human gut microbiota in relation to Clostridium difficile associated diarrhea.
Topics: Ampicillin; beta-Lactams; Cephalosporins; Clostridioides difficile; Clostridium Infections; Diarrhea; Fluoroquinolones; Gastrointestinal Tract; Humans; Microbiota; RNA, Ribosomal, 16S; Sulbactam | 2014 |
[Mechanism of drug resistance of carbapenems-resistant Acinetobacter baumannii and the application of a combination of drugs in vitro].
Topics: Acinetobacter baumannii; Acinetobacter Infections; Ampicillin; Anti-Bacterial Agents; beta-Lactamase Inhibitors; Carbapenems; Cefepime; Cephalosporins; Drug Resistance; Humans; In Vitro Techniques; Meropenem; Microbial Sensitivity Tests; Penicillanic Acid; Pharmaceutical Preparations; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sulbactam; Thienamycins | 2014 |
Trends in Susceptibility Rates and Extended-Spectrum β-Lactamase Production of Klebsiella pneumoniae in Bloodstream Infections Across the United States Veterans Affairs Healthcare System.
Topics: Amikacin; Ampicillin; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; beta-Lactams; Cefepime; Cefoxitin; Ceftazidime; Cephalosporins; Drug Resistance, Multiple, Bacterial; Ertapenem; Fluoroquinolones; Gene Expression Regulation, Bacterial; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Sulbactam; United States; United States Department of Veterans Affairs | 2015 |
The postantibiotic effect and post-β-lactamase-inhibitor effect of ceftazidime, ceftaroline and aztreonam in combination with avibactam against target Gram-negative bacteria.
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Aztreonam; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; Ceftaroline; Ceftazidime; Cephalosporins; Drug Combinations; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Sulbactam | 2016 |
Trends in Drug Resistance of
Topics: Acinetobacter baumannii; Amikacin; Anti-Infective Agents; Cefepime; Cefoperazone; Ceftazidime; Cephalosporins; China; Colistin; Drug Resistance, Multiple, Bacterial; Humans; Imipenem; Levofloxacin; Microbial Sensitivity Tests; Minocycline; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sulbactam | 2017 |
AmpC beta-lactamases in Klebsiella pneumoniae: An emerging threat to the paediatric patients.
Topics: Adolescent; Amikacin; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Cefoperazone; Cefoxitin; Cephalosporins; Child; Child, Preschool; Ciprofloxacin; Cross-Sectional Studies; Disk Diffusion Antimicrobial Tests; Drug Combinations; Drug Resistance, Bacterial; Female; Hospitals, Pediatric; Humans; Imipenem; Infant; Infant, Newborn; Klebsiella Infections; Klebsiella pneumoniae; Levofloxacin; Male; Meropenem; Microbial Sensitivity Tests; Pakistan; Piperacillin, Tazobactam Drug Combination; Sulbactam | 2018 |
Unorthodox Parenteral β-Lactam and β-Lactamase Inhibitor Combinations: Flouting Antimicrobial Stewardship and Compromising Patient Care.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Antimicrobial Stewardship; beta-Lactamase Inhibitors; Cephalosporins; China; Drug Combinations; Drug Misuse; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Inappropriate Prescribing; India; Microbial Sensitivity Tests; Patient Care; Pseudomonas aeruginosa; Pseudomonas Infections; Sulbactam; Tazobactam | 2020 |
First report on multidrug-resistant non-encapsulated Streptococcus pneumoniae isolated from a patient with pneumonia.
Topics: Adolescent; Ampicillin; Anti-Bacterial Agents; Cefozopran; Cephalosporins; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Humans; Microbial Sensitivity Tests; Myopathies, Structural, Congenital; Ophthalmoplegia; Pneumonia, Pneumococcal; Ryanodine Receptor Calcium Release Channel; Sputum; Streptococcus pneumoniae; Sulbactam | 2020 |
Resistance pattern of infected chronic wound isolates and factors associated with bacterial resistance to third generation cephalosporins at Mbarara Regional Referral Hospital, Uganda.
Topics: Adult; Aged; Anti-Bacterial Agents; Cefixime; Cefoperazone; Cefpodoxime; Ceftizoxime; Cephalosporins; Chronic Disease; Drug Resistance, Bacterial; Female; Hospitals; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Sulbactam; Uganda; Wound Infection | 2021 |
[The importance of microbiological results for the treatment of complicated appendicitis-a monocentric case-control study].
Topics: Ampicillin; Anti-Bacterial Agents; Appendicitis; Case-Control Studies; Cephalosporins; Escherichia coli; Humans; Metronidazole; Piperacillin, Tazobactam Drug Combination; Postoperative Complications; Sulbactam | 2022 |
Molecular and Kinetic Characterization of MOX-9, a Plasmid-Mediated Enzyme Representative of a Novel Sublineage of MOX-Type Class C β-Lactamases.
Topics: Bacterial Proteins; beta-Lactamases; Cephalosporins; Clavulanic Acid; Kinetics; Plasmids; Sulbactam; Tazobactam | 2022 |
Early treatment response to piperacillin/tazobactam in patients with bloodstream infections caused by non-ESBL ampicillin/sulbactam-resistant Escherichia coli: a binational cohort study.
Topics: Adult; Ampicillin; Anti-Bacterial Agents; Bacteremia; Cephalosporins; Cohort Studies; Escherichia coli; Escherichia coli Infections; Humans; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Quinolones; Retrospective Studies; Sulbactam | 2023 |